Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ONCY exchanges : Nasdaq save search
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: 0.0%
biotech fda breast cancer for meeting trial submission
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-03-07 (Crawled : 21:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 2.88%
H: 4.67%
C: -1.87%
biotech year financial results
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
Published: 2024-03-05 (Crawled : 12:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 6.52%
H: 6.12%
C: 5.1%
biotech cancer pancreatic
Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -0.74%
H: 0.74%
C: -8.15%
biotech
Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS
Published: 2023-12-07 (Crawled : 18:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 2.92%
H: 0.0%
C: -0.71%
biotech positive sabcs
Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
Published: 2023-11-03 (Crawled : 16:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 0.56%
C: -3.91%
biotech positive
Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
Published: 2023-11-03 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 0.56%
C: -3.91%
biotech financial results
Oncolytics Achieves Success Criteria for Efficacy in the Third-Line Colorectal Cancer Cohort of the GOBLET Study
Published: 2023-10-23 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.65%
H: 9.94%
C: 8.33%
success cancer study
Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO
Published: 2023-10-23 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.65%
H: 9.94%
C: 8.33%
positive cancer pancreatic study
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
Published: 2023-10-20 (Crawled : 14:30) - prnewswire.com
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.85%
H: 3.14%
C: -2.52%
MYGN | $18.595 0.57% 0.56% 510K
|
Health Technology
|
| O: 0.41%
H: 3.13%
C: 2.38%
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: 0.02%
H: 0.94%
C: -0.3%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -1.46%
H: 0.48%
C: -1.06%
companies biotech cancer pancreatic treatment research
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
Published: 2023-10-20 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.85%
H: 3.14%
C: -2.52%
biotech conference financial results
Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023
Published: 2023-10-16 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 1.61%
H: 1.59%
C: -3.17%
biotech study
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review
Published: 2023-10-13 (Crawled : 13:00) - prnewswire.com
PYXS | $4.48 -1.1% -1.12% 380K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 2.56%
C: 2.56%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.63%
H: 4.97%
C: 2.76%
MRUS | $40.75 0.74% 0.74% 570K
|
Health Technology
|
| O: 0.47%
H: 1.7%
C: -0.38%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.59%
H: 0.62%
C: -0.56%
fda year review cancer pancreatic
THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS
Published: 2023-09-26 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 5.63%
C: 4.69%
biotech award cancer pancreatic network
Pancreatic Cancer Battle Boosted by $200M VC Firm
Published: 2023-09-19 (Crawled : 17:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.47%
H: 4.98%
C: 3.98%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.13%
H: 2.0%
C: 1.83%
MACK 4 | $14.73 0.0% 80K
|
Health Technology
|
| O: -0.41%
H: 0.9%
C: 0.74%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.03%
H: 2.18%
C: 1.8%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -0.01%
H: 1.99%
C: 1.28%
cancer pancreatic
Oncolytics Biotech® Announces Fireside Chat at the Cantor Global Healthcare Conference
Published: 2023-09-19 (Crawled : 14:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.47%
H: 4.98%
C: 3.98%
biotech conference global
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
Published: 2023-09-13 (Crawled : 14:30) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -2.2%
H: 0.9%
C: -1.8%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.26%
H: 0.69%
C: 0.4%
FULC | $7.445 2.69% 2.62% 510K
|
Health Technology
|
| O: -0.19%
H: 0.0%
C: -8.83%
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: -1.12%
H: 3.87%
C: -1.94%
RNA | News M | $25.12 3.97% 3.82% 860K
|
Health Technology
|
| O: 1.25%
H: 3.01%
C: -2.6%
fda biotech momentum
Oncolytics Biotech® Reports Second Quarter 2023 Financial Results and Operational Highlights
Published: 2023-08-14 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -3.67%
H: 0.95%
C: -2.38%
biotech financial results
Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights
Published: 2023-08-04 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -4.93%
H: 0.0%
C: 0.0%
biotech conference financial results
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference
Published: 2023-08-04 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -4.93%
H: 0.0%
C: 0.0%
biotech conference growth
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.